New Trends in Vaccines Development

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine the discovery of novel antigens, adjuvants, and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines, and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

  • Antigen discovery
  • Immunological challenges
  • Aspects of pathology and host responses
  • Expanded testing and modelling of vaccine
  • Chloroplast-derived vaccines antigens and therapeutics

Related Conference of New Trends in Vaccines Development

October 30-31, 2020

32nd Annual Congress on Immunology and Vaccinations

Vancouver, Canada

New Trends in Vaccines Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in